IL73871A0 - Amino acid solutions - Google Patents

Amino acid solutions

Info

Publication number
IL73871A0
IL73871A0 IL73871A IL7387184A IL73871A0 IL 73871 A0 IL73871 A0 IL 73871A0 IL 73871 A IL73871 A IL 73871A IL 7387184 A IL7387184 A IL 7387184A IL 73871 A0 IL73871 A0 IL 73871A0
Authority
IL
Israel
Prior art keywords
amino acids
essential
semi
solutions
weight
Prior art date
Application number
IL73871A
Other languages
English (en)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9295350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL73871(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL73871A0 publication Critical patent/IL73871A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL73871A 1983-12-20 1984-12-19 Amino acid solutions IL73871A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8320383A FR2556594B1 (fr) 1983-12-20 1983-12-20 Solutions d'acides amines

Publications (1)

Publication Number Publication Date
IL73871A0 true IL73871A0 (en) 1985-03-31

Family

ID=9295350

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73871A IL73871A0 (en) 1983-12-20 1984-12-19 Amino acid solutions

Country Status (16)

Country Link
EP (1) EP0148680B1 (de)
JP (1) JPS60166612A (de)
KR (1) KR850004390A (de)
AT (1) ATE38331T1 (de)
AU (1) AU565840B2 (de)
CA (1) CA1235598A (de)
DE (1) DE3474914D1 (de)
DK (1) DK611184A (de)
FR (1) FR2556594B1 (de)
GR (1) GR82510B (de)
IL (1) IL73871A0 (de)
MA (1) MA20304A1 (de)
NZ (1) NZ210638A (de)
OA (1) OA07905A (de)
PT (1) PT79713B (de)
ZA (1) ZA849906B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1257806A (en) * 1984-11-19 1989-07-25 Siamak A. Adibi Nutrient compositions
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
FR2605854B1 (fr) * 1986-10-30 1990-07-06 Futur Quotidien Sa Complement dietetique a des fins energetiques
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
DE3916903A1 (de) * 1989-05-24 1991-02-28 Leopold Pharma Gmbh Waessrige zusammensetzung fuer die parenterale ernaehrung
FI904074A7 (fi) * 1989-08-28 1991-03-01 Milupa Ag Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
CN1110112A (zh) * 1994-04-11 1995-10-18 贾增申 一种氨基酸固体饮料及其制备方法
GB0009056D0 (en) 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
EP2922414B1 (de) * 2012-11-23 2019-11-13 N.V. Nutricia Formulierungen mit optimierten aminosäureprofilen
EP3145333B1 (de) 2014-05-19 2020-11-04 N.V. Nutricia Säuglingsnahrungsformulierung mit optimierten aminosäure-profilen
EP3338841A1 (de) * 2016-12-23 2018-06-27 Ferdinand Haschke Flüssiger muttermilchzusatz
GB201807155D0 (en) * 2018-05-01 2018-06-13 Liverpool Womens Trust Nhs Found Trust Neonatal Parenteral nutrition formulations
JP7714330B2 (ja) * 2020-09-08 2025-07-29 デンカ株式会社 偽陽性の抑制により特異性を改善した検査キット
JP7714329B2 (ja) * 2020-09-08 2025-07-29 デンカ株式会社 偽陰性の抑制により特異性を改善した検査試薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
US4491589A (en) * 1982-05-17 1985-01-01 The Trustees Of Columbia University In The City Of New York Amino acid solutions for parenteral nutrition and methods of formulation and use

Also Published As

Publication number Publication date
ATE38331T1 (de) 1988-11-15
PT79713A (fr) 1985-01-01
JPS60166612A (ja) 1985-08-29
DE3474914D1 (en) 1988-12-08
OA07905A (fr) 1986-11-20
PT79713B (fr) 1986-12-30
CA1235598A (en) 1988-04-26
AU3691284A (en) 1985-07-04
DK611184D0 (da) 1984-12-19
NZ210638A (en) 1987-05-29
GR82510B (en) 1985-04-22
AU565840B2 (en) 1987-10-01
FR2556594B1 (fr) 1988-09-09
EP0148680B1 (de) 1988-11-02
FR2556594A1 (fr) 1985-06-21
DK611184A (da) 1985-06-21
EP0148680A1 (de) 1985-07-17
KR850004390A (ko) 1985-07-15
MA20304A1 (fr) 1985-07-01
ZA849906B (en) 1985-08-28

Similar Documents

Publication Publication Date Title
DE3474914D1 (en) Amino-acid solutions
Poullain et al. Effect of whey proteins, their oligopeptide hydrolysates and free amino acid mixtures on growth and nitrogen retention in fed and starved rats
ATE198122T1 (de) Konzentrierte, bioverfügbare kalziumquelle
JPS56110617A (en) Nutrient composition for young child
DK96386D0 (da) Faste biocid-toerblandingskoncentrater og deres fremstilling
CA2191344A1 (en) Synthetic peptide analogs of lung surfactant protein sp-c
JPS6490123A (en) Nitroglycerol spray agent
DE3887291D1 (de) Verfahren zur Herstellung von N,N'-Dimethyl-perylen-3,4,9,10-tetracarbonsäurediimid in hochdeckender Pigmentform.
JPS559023A (en) Production of dopa preparation in high concentration
JPS5721311A (en) Novel cold-wave lotion
PT84064A (en) Process for the preparation of novel amino acid derivatives and of pharmaceutical compositions containing the same
ZA879011B (en) Variants of hirudin,their use and their preparation
GR77543B (de)
EP0236020A3 (en) A toy having the appearance of a boat
ATE11053T1 (de) Transparentes, kochwasserbestaendiges und sterilisationsfestes polyamid.
EP0269516A3 (de) Ursodesoxycholsäure enthaltende pharmazeutische Präparate
IL67411A0 (en) Crystalline human leukocyte interferon,its production and pharmaceutical compositions containing it
JPS5483054A (en) Polyamide composition
JPS5533446A (en) Amino acid transfusion for postoperative patient
Peter et al. Metabolism of S-methyl glutathione by intestinal microflora during enterohepatic circulation in rats and mice
ATE122714T1 (de) Kaltwasserlösliche, in partikeln oder blättchen überführbare, seifenzusammensetzung.
Mukhtar et al. Measles in a two-months age baby and his mother in Juba, Sudan
JPS55104847A (en) Artificial granule and its preparation
Kolomoets The amino acid composition of the blood serum and gastric mucosa in peptic ulcer with involvement of the hepatobiliary system and intestines in patients of different ages (1)
Hawkins The effects of oral supplementation of the amino acid arginine on body composition and muscle function during energy restriction in male weight lifters